Holen Sie sich die Stockscreener-App
9.69
0.62%
0.06
Schlusskurs vom Vortag:
$9.63
Offen:
$9.64
24-Stunden-Volumen:
3.35M
Relative Volume:
0.95
Marktkapitalisierung:
$1.03B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-766.97M
KGV:
-1.265
EPS:
-7.66
Netto-Cashflow:
$-646.43M
1W Leistung:
+16.75%
1M Leistung:
-45.35%
6M Leistung:
-38.28%
1J Leistung:
-78.56%
1-Tages-Spanne:
$9.295
$10.04
1-Wochen-Bereich:
$7.99
$10.28
52-Wochen-Spanne:
$7.48
$47.75
Biohaven Ltd Stock (BHVN) Company Profile
Firmenname
Biohaven Ltd
Sektor
Branche
Telefon
203-404-0410
Adresse
215 CHURCH STREET, NEW HAVEN, CT
Vergleichen Sie BHVN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BHVN
Biohaven Ltd
|
9.69 | 1.28B | 0 | -766.97M | -646.43M | -7.66 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Biohaven Ltd Stock (BHVN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-06 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2025-11-05 | Herabstufung | BofA Securities | Buy → Neutral |
| 2025-09-17 | Eingeleitet | Citigroup | Buy |
| 2025-09-03 | Eingeleitet | Raymond James | Strong Buy |
| 2025-05-19 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2025-02-11 | Eingeleitet | Deutsche Bank | Buy |
| 2024-09-16 | Eingeleitet | Jefferies | Buy |
| 2024-09-04 | Eingeleitet | Bernstein | Outperform |
| 2024-07-24 | Eingeleitet | Morgan Stanley | Overweight |
| 2024-02-16 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2024-02-06 | Eingeleitet | UBS | Buy |
| 2023-12-22 | Eingeleitet | H.C. Wainwright | Buy |
| 2023-12-08 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-01-24 | Eingeleitet | SVB Securities | Outperform |
| 2023-01-04 | Eingeleitet | JP Morgan | Overweight |
| 2022-12-02 | Eingeleitet | BTIG Research | Buy |
| 2022-10-26 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2022-10-12 | Eingeleitet | Piper Sandler | Overweight |
| 2022-08-19 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-08-08 | Herabstufung | Wedbush | Outperform → Neutral |
| 2022-05-11 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2021-10-19 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2021-08-10 | Herabstufung | UBS | Buy → Neutral |
| 2021-08-03 | Bestätigt | Canaccord Genuity | Buy |
| 2021-03-11 | Eingeleitet | UBS | Buy |
| 2020-12-15 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-04-17 | Eingeleitet | Cowen | Outperform |
| 2020-02-10 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2020-02-06 | Eingeleitet | Mizuho | Buy |
| 2019-11-22 | Eingeleitet | Wedbush | Outperform |
| 2019-06-25 | Bestätigt | Canaccord Genuity | Buy |
| 2019-05-06 | Eingeleitet | Goldman | Buy |
| 2019-04-09 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2019-03-04 | Bestätigt | Needham | Buy |
| 2018-07-03 | Bestätigt | Needham | Buy |
| 2018-07-02 | Bestätigt | Needham | Buy |
| 2018-04-05 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2018-02-22 | Bestätigt | Canaccord Genuity | Buy |
| 2017-12-15 | Eingeleitet | Canaccord Genuity | Buy |
| 2017-10-03 | Bestätigt | Needham | Buy |
Alle ansehen
Biohaven Ltd Aktie (BHVN) Neueste Nachrichten
Will Biohaven's (BHVN) $175 Million Equity Raise Reshape Its Path to Financial Strength? - simplywall.st
Biohaven Ltd. (BHVN) Stock Price | Live Quotes & Charts | NYSE - StocksToTrade
William Blair Maintains Bullish Stance on Biohaven (BHVN), Sees Robust Operational Growth - MSN
Is Biohaven Ltd. Common Shares stock undervalued historically2025 Performance Recap & Stepwise Trade Execution Plans - newser.com
Biohaven Insiders Bet $33 Million on a Turnaround - MarketBeat
Biohaven price target lowered to $15 from $47 at JPMorgan - TipRanks
How Biohaven Ltd. stock reacts to inflationary pressuresJuly 2025 Market Mood & Target Return Focused Picks - newser.com
Should I buy Biohaven Ltd. Common Shares stock before earnings season2025 EndofYear Setup & Intraday High Probability Alerts - newser.com
How Biohaven Ltd. stock benefits from global expansionAnalyst Upgrade & Technical Pattern Based Signals - newser.com
Can Biohaven Ltd. Common Shares stock sustain double digit ROEJuly 2025 Fed Impact & AI Driven Price Forecasts - newser.com
Is Biohaven Ltd. stock vulnerable to regulatory risks2025 Top Gainers & AI Enhanced Trading Alerts - newser.com
Why hedge funds are buying Biohaven Ltd. stockQuarterly Portfolio Review & High Conviction Trade Alerts - newser.com
What MACD trends signal for Biohaven Ltd. Common Shares stockPortfolio Profit Report & High Win Rate Trade Alerts - newser.com
What Fibonacci levels say about Biohaven Ltd. reboundWeekly Loss Report & Free Long-Term Investment Growth Plans - newser.com
Building trade automation scripts for Biohaven Ltd.2025 Volume Leaders & Free High Return Stock Watch Alerts - newser.com
Biohaven's Chief Accounting Officer Scooped Up 17,000 Shares. Is the Stock a Buy? - The Motley Fool
Biohaven's Chief Accounting Officer Scooped Up 17,000 Shares. Is the Stock a Buy? - The Motley Fool
Why Biohaven Ltd. stock is favored by pension fundsQuarterly Performance Summary & Fast Moving Market Watchlists - newser.com
Signal strength of Biohaven Ltd. stock in tech scanners2025 Top Gainers & Risk Controlled Daily Trade Plans - newser.com
Can Biohaven Ltd. stock resist sector downturnsJuly 2025 Recap & Pattern Based Trade Signal System - newser.com
Has Biohaven Ltd. formed a bullish divergenceJuly 2025 Chart Watch & Low Drawdown Investment Ideas - newser.com
Market reaction to Biohaven Ltd.’s recent newsQuarterly Trade Review & Free Accurate Trade Setup Notifications - newser.com
Independent Director of Biohaven John Childs Buys 52% More Shares - simplywall.st
Will Biohaven Ltd. stock reach Wall Street targetsMarket Performance Recap & Growth Oriented Trading Recommendations - newser.com
Top Executive Makes Major Stock Purchase in Biohaven Ltd. - TipRanks
Strategic Adjustments and Future Potential: Biohaven Ltd. Receives Buy Rating Amidst Regulatory Challenges - TipRanks
Biohaven CEO and Directors Make Major Stock Purchases - StocksToTrade
BHVN: Morgan Stanley Lowers Price Target Amidst Market Volatilit - GuruFocus
Hedge Fund and Insider Trading News: Bill Ackman, Michael Burry, Marshall Wace, Armistice Capital, Exploration Capital, Zweig-DiMenna, Biohaven Ltd (BHVN), and More - Insider Monkey
Finanzdaten der Biohaven Ltd-Aktie (BHVN)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.38%
1.42%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):